Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells
Sebastian Hasslacher(Kantonsspital St. Gallen), Mike‐Andrew Westhoff(Universität Ulm)
Cited by 15
Related Papers
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
|Biomedicines|2019|276